DIN 02536161 — APO-DAPAGLIFLOZIN-METFORMIN 1000 MG; 5 MG
APO-DAPAGLIFLOZIN-METFORMIN is a tablet of Dapagliflozin / Metformin marketed by APOTEX INC. The full Dapagliflozin / Metformin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02536161
- Brand name
- APO-DAPAGLIFLOZIN-METFORMIN
- Active ingredient
- Dapagliflozin / Metformin
- Strength
- 1000 MG; 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Sodium-glucose co-transporter 2 (SGLT2) inhibitor and biguanide combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Dapagliflozin / Metformin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02536153 | APO-DAPAGLIFLOZIN-METFORMIN | 850 MG; 5 MG | TABLET | APOTEX INC | MARKETED |
| 02533081 | AURO-DAPAGLIFLOZIN / METFORMIN | 5 MG; 1000 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02533073 | AURO-DAPAGLIFLOZIN / METFORMIN | 5 MG; 850 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02449943 | XIGDUO | 1000 MG; 5 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |
| 02449935 | XIGDUO | 5 MG; 850 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |